Latest Global Markets News

EVE Health Group has increased its placement funding to $1.3 million, backed by a cornerstone investor with pharmaceutical expertise, advancing its reformulated drug programs targeting billion-dollar global markets.

BCI Minerals confirms the Mardie Salt and Potash Project remains on track for first salt shipment in the second half of 2026, supported by binding offtake agreements and a positive salt price outlook driven by supply shortfalls in Asia.

Image Resources NL is set to record significant non-cash impairments totalling around A$61 million in its 2025 financial results, reflecting challenges from weaker mineral sands prices and a stronger Australian dollar.

Lynas Rare Earths has inked a binding Letter of Intent with the US Department of War to supply critical rare earth oxides over four years, backed by a US$96 million government allocation and a US$110/kg floor price for NdPr oxide.

Oneview Healthcare has successfully raised A$19 million through a two-tranche placement and launched a Security Purchase Plan to further strengthen its financial position and accelerate AI development.

EVE Health Group has raised $0.9 million to advance its pharmaceutical reformulation programs targeting global markets worth over US$30 billion. The funding will support development of improved delivery technologies for medicines nearing patent expiry.

Quantum Graphite’s partner Sunlands Pure Group has signed a key MOU with Oman’s Al Buraimi Governorate to develop a large-scale graphite refinery, positioning Quantum as the exclusive graphite supplier for global battery and energy markets.

Australian Oil Company Limited has formalised a 12-month crude oil lifting agreement with IOR Energy for its Emu Apple Oil Field, paving the way for steady cash flow and further development in the Surat Basin.

American Tungsten & Antimony Ltd (AT4) has submitted a drilling permit for the historic Fraction Lode tungsten mine and commenced refurbishment of its Dutch Mountain processing mill, marking a pivotal step in its US tungsten supply chain strategy.

Titomic Limited is planning to redomicile from Australia to the United States, aiming to deepen its footprint in the US defense and aerospace sectors and pursue a US stock exchange listing.

EVE Health Group has completed R&D on multiple reformulated drug candidates targeting major sexual health and cardiovascular markets, preparing patent filings and licensing strategies to capitalise on a combined $30 billion global opportunity.

New Frontier Minerals has confirmed significant high-grade tungsten mineralisation at its Harts Range Project in the Northern Territory, complementing its rare earth focus and capitalising on a soaring tungsten market. Meanwhile, its Pomme Rare Earth Project in Quebec advances with promising metallurgical testing underway.